Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy.

Bernt A, Rangrez AY, Eden M, Jungmann A, Katz S, Rohr C, Müller OJ, Katus HA, Sossalla ST, Williams T, Ritter O, Frank D, Frey N.

Sci Rep. 2016 Oct 21;6:35758. doi: 10.1038/srep35758.

2.

Allosteric activation of SENP1 by SUMO1 β-grasp domain involves a dock-and-coalesce mechanism.

Guo J, Zhou HX.

Elife. 2016 Aug 31;5. pii: e18249. doi: 10.7554/eLife.18249.

3.

SUMO enters the ring.

Short B.

J Cell Biol. 2015 Nov 9;211(3):490. doi: 10.1083/jcb.2113fta. No abstract available.

4.

mRNA expression analysis of the SUMO pathway genes in the adult mouse retina.

Abad-Morales V, Domènech EB, Garanto A, Marfany G.

Biol Open. 2015 Jan 23;4(2):224-32. doi: 10.1242/bio.201410645.

5.

Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction.

Henley JM, Craig TJ, Wilkinson KA.

Physiol Rev. 2014 Oct;94(4):1249-85. doi: 10.1152/physrev.00008.2014. Review.

6.

SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets.

Hajmrle C, Ferdaoussi M, Plummer G, Spigelman AF, Lai K, Manning Fox JE, MacDonald PE.

Am J Physiol Endocrinol Metab. 2014 Oct 15;307(8):E664-73. doi: 10.1152/ajpendo.00168.2014.

7.

Influence of ND10 components on epigenetic determinants of early KSHV latency establishment.

Günther T, Schreiner S, Dobner T, Tessmer U, Grundhoff A.

PLoS Pathog. 2014 Jul 17;10(7):e1004274. doi: 10.1371/journal.ppat.1004274.

8.

Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.

Mascle XH, Lussier-Price M, Cappadocia L, Estephan P, Raiola L, Omichinski JG, Aubry M.

J Biol Chem. 2013 Dec 20;288(51):36312-27. doi: 10.1074/jbc.M113.486845.

9.

Sumoylation at the host-pathogen interface.

Wilson VG.

Biomolecules. 2012 Apr 5;2(2):203-27. doi: 10.3390/biom2020203.

10.

Role of Ser129 phosphorylation of α-synuclein in melanoma cells.

Lee BR, Matsuo Y, Cashikar AG, Kamitani T.

J Cell Sci. 2013 Jan 15;126(Pt 2):696-704. doi: 10.1242/jcs.122093.

11.

Poly-small ubiquitin-like modifier (PolySUMO)-binding proteins identified through a string search.

Sun H, Hunter T.

J Biol Chem. 2012 Dec 7;287(50):42071-83. doi: 10.1074/jbc.M112.410985.

12.

Human pathogens and the host cell SUMOylation system.

Wimmer P, Schreiner S, Dobner T.

J Virol. 2012 Jan;86(2):642-54. doi: 10.1128/JVI.06227-11. Review.

13.

SUMO and SUMOylation in plants.

Park HJ, Kim WY, Park HC, Lee SY, Bohnert HJ, Yun DJ.

Mol Cells. 2011 Oct;32(4):305-16. doi: 10.1007/s10059-011-0122-7. Review.

14.

SUMO1-dependent modulation of SERCA2a in heart failure.

Kho C, Lee A, Jeong D, Oh JG, Chaanine AH, Kizana E, Park WJ, Hajjar RJ.

Nature. 2011 Sep 7;477(7366):601-5. doi: 10.1038/nature10407.

15.

In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induced Daxx sumoylation.

Hwang J, Kalejta RF.

Methods. 2011 Oct;55(2):160-5. doi: 10.1016/j.ymeth.2011.07.004.

16.
17.

A mechanistic view of the role of E3 in sumoylation.

Tozluoğlu M, Karaca E, Nussinov R, Haliloğlu T.

PLoS Comput Biol. 2010 Aug 26;6(8). pii: e1000913. doi: 10.1371/journal.pcbi.1000913.

18.

Cytoplasmic relocation of Daxx induced by Ro52 and FLASH.

Tanaka M, Kamitani T.

Histochem Cell Biol. 2010 Sep;134(3):297-306. doi: 10.1007/s00418-010-0734-6.

19.

Emerging roles of SUMO modification in arthritis.

Yan D, Davis FJ, Sharrocks AD, Im HJ.

Gene. 2010 Oct 15;466(1-2):1-15. doi: 10.1016/j.gene.2010.07.003. Review.

20.

Mechanisms, regulation and consequences of protein SUMOylation.

Wilkinson KA, Henley JM.

Biochem J. 2010 May 13;428(2):133-45. doi: 10.1042/BJ20100158. Review.

Items per page

Supplemental Content

Support Center